Labcorp Holdings LH Diagnostics — Depreciation
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Labcorp Holdings in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The official record: Labcorp Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Labcorp Holdings's diagnostics — depreciation.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Labcorp Holdings's diagnostics — depreciation?
- Labcorp Holdings (LH) reported diagnostics — depreciation of $63.8M in Q1 2026.
- How has Labcorp Holdings's diagnostics — depreciation changed year-over-year?
- Labcorp Holdings's diagnostics — depreciation increased by 3.4% year-over-year, from $61.7M to $63.8M.
- What is the long-term trend for Labcorp Holdings's diagnostics — depreciation?
- Over 4 years (2021 to 2025), Labcorp Holdings's diagnostics — depreciation has grown at a 2.1% compound annual growth rate (CAGR), from $238.6M to $258.8M.
- What does diagnostics — depreciation mean?
- This reflects the systematic allocation of the cost of tangible assets, such as laboratory equipment, testing machinery, and facility improvements, over their useful lives within the diagnostics segment. It represents the non-cash consumption of capital investments.